Mohamed Genead

Biography

Dr Genead is an Ophthalmologist, Medical retina specialist and a senior biopharmaceutical executive with more than 15 years of experience in Ophthalmology clinical research. He most recently served as Biogen Global Therapeutic Area Head of Ophthalmology and Retina Gene Therapy Areas where he led multiple gene-therapy programs in inherited retinal degenerative diseases. Prior to joining Biogen, Mohamed was the Global Head of Clinical Development at Allegro Ophthalmic, where he led the global clinical development teams. Prior to this, Mohamed was Global project and clinical teams Lead for early proof of concept and late registration development programs in retina at Allergan, where he led projects as DARPins for wet AMD and DME and Brimonidine DDS implants for geographic atrophy. Before joining the industry, Mohamed spent years in academia serving as co-director of center for retina degenerative diseases, as an investigator and as clinician at University of Illinois in Chicago. He is a member of numerous professional and honorary societies. He was the primary and key author for numerous key peer-reviewed manuscripts. Mohamed had his medical and fellowship training at Medical College of Wisconsin and the University of Illinois in Chicago.

Research Interest

Ophthalmology clinical research